Skip to main content
. 2021 Oct 13;42(4-5):291–301. doi: 10.1177/03331024211048765

Table 3.

Monthly headache days and acute medication days during observation period 1.

Observation Period 1 (Change from baseline)
Baseline Month 1 Month 2 Month 3
Mean Mean difference Mean difference Mean difference
Total cohort n (SD) (95% CI) (95% CI) (95% CI)
 Monthly Headache Days 25 21.1 (6.7) −0.6 (−1.8 to 0.6) −0.6 (−2.0 to 0.8) −0.4 (−1.6 to 0.9)
 Acute Medication Days 17 8.5 (3.0) −1.4 (−3.9 to 1.0) −1.5 (−3.5 to 0.5) −1.4 (−3.0 to 0.3)
Non-daily headache
 Monthly Headache Days 16 17.2 (5.3) −0.3 (−1.9 to 1.4) −0.5 (−2.8 to 1.8) −0.4 (−2.4 to 1.6)
 Acute Medication Days 10 8.8 (3.0) −0.5 (−3.3 to 2.3) −2.0 (−4.6 to 0.6) −1.6 (−3.6 to 0.4)
Daily headache
 Monthly Headache Days 9 28.0 (0.0) −1.3 (−3.1 to 0.4) −0.8 (−1.6 to 0.1) −0.3 (−0.9 to 0.2)
 Acute Medication Days 7 8.1 (9.0) −2.7 (−8.1 to 2.7) −0.7 (−4.8 to 3.4) −1.0 (−4.8 to 2.8)

SD = standard deviation; 95% CI = 95% confidence interval.